Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Bendamustine products are in shortage in Canada (2 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A chemotherapy medication used to treat certain leukemias and lymphomas.
Products affected
2 / 8
In shortage since
Jul 19, 2022
Reports on file
9
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
25MG · POWDER FOR SOLUTION · JAMP PHARMA CORPORATION
DIN 02509164 · since Jul 19, 2022, est. end Jan 1, 2025 · Disruption of the manufacture of the drug.
Active shortage
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
100MG · POWDER FOR SOLUTION · JAMP PHARMA CORPORATION
DIN 02509172 · since Jul 19, 2022, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Resolved
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
100MG · POWDER FOR SOLUTION · ACCORD HEALTHCARE INC
DIN 02496860 · ended Jan 9, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
25MG · POWDER FOR SOLUTION · ACCORD HEALTHCARE INC
DIN 02496852 · ended Jan 9, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
TREANDA
100MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02392569 · ended May 1, 2025 · Disruption of the manufacture of the drug.
Resolved
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
100MG · POWDER FOR SOLUTION · AURO PHARMA INC
DIN 02509261 · ended Feb 18, 2025 · Product is available under Eugia Label
Resolved
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
25MG · POWDER FOR SOLUTION · AURO PHARMA INC
DIN 02509253 · ended Feb 18, 2025 · This Product is available under Eugia Label.
Resolved
TREANDA
25MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02392550 · ended Jan 16, 2025 · Disruption of the manufacture of the drug.
Resolved
TREANDA
100MG · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02392569 · ended Feb 10, 2021 · Disruption of the manufacture of the drug.
What's happening
Bendamustine is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Bendamustine is classified under “ALKYLATINGAGENTS” (ATC L01AA).
Recent changes
No changes recorded yet.
Common questions
What is Bendamustine used for?
A chemotherapy medication used to treat certain leukemias and lymphomas.
When will Bendamustine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Bendamustine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.